Another recent study reported a loss of WNT activity in AD patients showing decreased β-catenin levels and increased phosphorylation of GSK3β in the cortical lobes of AD brains compared to age-matched controls [125]. This evidence concerns the gene GSK3B and Alzheimer disease.